Home・Stock List・Erasca Inc

Erasca Inc

Closed

21.27 9.47

Buy Sell

Overview

Share price change

24h

Current

Min

19.49

Max

21.59

Key metrics
By Trading Economics
Income	-154M -183M
EPS	-0.6
Employees	103
EBITDA	-151M -183M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+15.69% upside

Dividends
By Acuity
Next Earnings	10 Aug 2026

Market Stats
By TradingEconomics
Market Cap	2.3B 5.6B
Previous open	11.8
Previous close	21.27

Erasca Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Jul 2026, 23:56 UTC

Correlated Moves

Skyworks Solutions Inc shares are higher in after-market trading, supported by positive sentiment in the semiconductor sector and strong earnings from major banks.

14 Jul 2026, 23:56 UTC

JD.Com Inc. shares advanced in after-market trading, supported by strong earnings from major banks and a positive market backdrop. The stock remains above its 20-day moving average.

14 Jul 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is higher in after-market trading, supported by favorable USD/CNH exchange rate movements and contributions from JD.

14 Jul 2026, 23:56 UTC

Vanguard Total International Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 Jul 2026, 23:56 UTC

iShares National Muni Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 Jul 2026, 23:52 UTC

Verisk Analytics Inc shares are lower in after-market hours, with no specific news identified. The decline contrasts with positive sentiment from strong bank earnings.

14 Jul 2026, 23:52 UTC

South Korea's June unemployment rate improves to 2.7%, boosting market confidence amid global economic recovery.

14 Jul 2026, 23:52 UTC

Brazil's Central Bank to Release Key SELIC Rate Insights Amid Global Inflation Concerns on July 20, 2026.

14 Jul 2026, 23:52 UTC

U.S. Industrial Production Data Release on July 17, 2026, Expected to Show Modest Growth Amid Cautious Economic Sentiment and Global Market Volatility.

14 Jul 2026, 23:52 UTC

China's Q2 GDP Growth Rate Expected to Slow to 0.9% Amid Strong Export Surge and Cautious Consumer Sentiment

14 Jul 2026, 23:52 UTC

Japan's upcoming Exports YoY report on July 21, 2026, is generating cautious optimism among investors amid positive regional trends and strong Chinese export data.

14 Jul 2026, 23:52 UTC

Japan's Upcoming Balance of Trade Data on July 21, 2026, Sparks Cautious Investor Sentiment Amidst Persistent Trade Deficits and Global Commodity Price Fluctuations.

14 Jul 2026, 23:51 UTC

U.S. Inflation Drops More Than Expected, Boosting European Equity Futures Amid Geopolitical Tensions

14 Jul 2026, 23:51 UTC

U.S. inflation drops unexpectedly, boosting global equity markets despite mixed results in the U.S. and ongoing geopolitical tensions affecting oil prices.

14 Jul 2026, 23:51 UTC

Asian equity markets rise on strong Chinese trade data, while U.S. stock futures react to softer inflation and mixed earnings amid geopolitical tensions.

14 Jul 2026, 23:51 UTC

U.S. equity markets show mixed results as weaker-than-expected inflation data eases rate hike fears, while geopolitical tensions and strong bank earnings drive volatility.

14 Jul 2026, 23:46 UTC

ETF Constituents

iShares Core MSCI EAFE ETF declines in after-market hours, influenced by top holdings BHP and TM. Performance remains flat since Tuesday's close.

14 Jul 2026, 23:46 UTC

ETF Constituents

iShares Biotechnology ETF declines in after-hours trading, continuing a trend of lower daily closes amid declines from key holdings like EDIT and ADPT.

14 Jul 2026, 23:46 UTC

MercadoLibre Inc shares are higher in after-market hours, supported by strong bank earnings that eased interest rate concerns. No specific news was identified for the stock.

14 Jul 2026, 23:46 UTC

News

PayPal Holdings Inc. shares are lower in after-market trading despite expanding buy now, pay later options in the UK with a new Pay in 30 Days feature.

14 Jul 2026, 23:42 UTC

Japan's Machinery Orders Expected to Decline by -4.2% MoM Amid Geopolitical Tensions and Market Caution

14 Jul 2026, 23:42 UTC

China's Fixed Asset Investment Expected to Contract Further Amid Weak Economic Indicators and Cautious Market Sentiment

14 Jul 2026, 23:42 UTC

China's Industrial Production YoY data for June 2026, expected to rise to 4.6%, set for release on July 15 amid cautious optimism influenced by strong trade figures and geopolitical tensions.

14 Jul 2026, 23:42 UTC

China's Retail Sales Expected to Decline by 0.1% YoY Amid Mixed Economic Signals Ahead of July Release

14 Jul 2026, 23:42 UTC

China's Q2 2026 GDP Growth Rate Expected at 4.5%, Amid Mixed Economic Signals and Global Uncertainties

14 Jul 2026, 23:42 UTC

Bank of Canada's Monetary Policy Report on July 15, 2026, expected to maintain interest rates amid stable inflation and geopolitical tensions.

14 Jul 2026, 23:41 UTC

Event

News

Biogen Inc shares are higher in after-market trading following positive Phase 2 CELIA study results for diranersen, which targets tau in early Alzheimer's disease.

14 Jul 2026, 23:41 UTC

Macro Event

Correlated Moves

Macro News

Crude oil prices have risen, reaching $79 per barrel amid U.S.-Iran tensions. The EUR/USD exchange rate is modestly higher since Monday's close.

14 Jul 2026, 23:41 UTC

Macro News

Macro Event

Correlated Moves

Bitcoin is rising as geopolitical tensions boost oil prices and soft U.S. inflation data eases rate hike fears. Ethereum's gains may further support Bitcoin's momentum.

14 Jul 2026, 23:36 UTC

Autodesk Inc shares advanced after-market, reaching a high of 0.78% since Tuesday's close, despite no specific news driving the movement.

Peer Comparison

Price change

Erasca Inc Forecast

Price Target

By TipRanks

15.69% upside

12 Months Forecast

Average 22.56 USD 15.69%

High 30 USD

Low 18 USD

Based on 9 Wall Street analysts offering 12 month price targets forErasca Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Erasca Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.